Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: Predicting outcomes with natural history models

Mayo Clinic Proceedings

Volumn 73, Issue 6, 1998, Pages 575-588

  Wiesner, Russell H ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

AGE; CONFERENCE PAPER; DISEASE SEVERITY; HEALTH CARE COST; HUMAN; LIVER TRANSPLANTATION; MATHEMATICAL MODEL; POSTOPERATIVE COMPLICATION; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; RESOURCE MANAGEMENT; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

EID: 0031781784     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.6.575     Document Type: Conference Paper

References (64)

1. UNOS Scientific Registry. Patients waiting for transplant. UNOS Bull 1997;2:9-10
2. Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992:16:1290-1299
3. National Institutes of Health Consensus Development Conference statement: liver transplantation-June 20-23, 1983. Hepatology 1984;4(Suppl):107S-110S
4. Lake JR. Changing indications for liver transplantation. Gastroenterol Clin North Am 1993 Jun;22:213-229
5. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979;20:137-140
6. Shaw BW Jr, Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985;5:385-393
7. UNOS Scientific Registry. Liver allocation data examined. UNOS Update 1991 Oct;7:ll-15
8. Delmonico FL, Jenkins RL, Freeman R, Vacant! J, Bradley J, Dienstag JL, et al. The high-risk liver allograft recipient: should allocation policy consider outcome? Arch Surg 1992;127:579-584
9. Baliga P, Merion RM, Turcotte JG, Ham JM, Henley KS, Lucey MR, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992:112:704-710
10. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (second of two parts). N Engl J Med 1989;321:1092-1099
11. Neuberger JM. Predicting the prognosis of primary biliary cirrhosis. Gut 1989:30:1519-1522
12. Kankaanpaa J. Cost-effectiveness of liver transplantations-how to apply the results in resource allocation. Prev Med 1990:19:700-704
13. Cox DR. Regression models and life-tables (with discussion). J R Stat SocB 1972:34:187-220
14. Schlichting P, Christensen E, Andersen PK, Fauerholdt L, Juhl E, Poulsen H, et al. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983;3:889-895
15. Nyberg A, Engstrom-Laurent A, Loof L. Serum hyaluronate in primary biliary cirrhosis-a biochemical marker for progressive liver damage. Hepatology 1988:8:142-146
16. Eriksson S, Zettervall 0. The N-terminal propeptide of collagen type II! in serum as a prognostic indicator in primary biliary cirrhosis. J Hepatol 1986:2:370-378
17. Clements D, Elias E, McMaster P. Preliminary study of indocyanine green clearance in primary biliary cirrhosis. Scand J Gastroenterol 1991;26:119-123
18. Reichen J, Widmer T, Cutting J. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model. Hepatology 1991:14:504-510
19. Beukers R, van Zanten RA, Schalm SW. Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis. J Hepatol 1992:14:22-29
20. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologie features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:l-7
21. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial. Gastroentemlogy 1985:89:1084-1091
22. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model of decision making. Hepatology 1989:10:1-7
23. Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 1989:10:846-850
24. Rydning A, Schrumpf E, Abdelnoor M, Elgio K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990:25:119-126
25. Goudie BM, Burt AD, Macfarlane GJ, Boyle P, Gillis CR, MacSween RN, et al. Risk factors and prognosis in primary biliary cirrhosis [published erratum appears in Am J Gastroenterol 1989;84:1474]. Am J Gastroenterol 1989;84:713-716
26. Jeffrey GP, Reed WD, Shilkin KB. Natural history and prognostic variables in primary biliary cirrhosis (PBC) [abstract]. Hepatology 1990;12:955
27. Kilon FM, Fabry TL, Palmer M, Schaffner F. Prediction of survival of patients with primary biliary cirrhosis: examination of the Mayo Clinic model on a group of patients with known endpoint. Gastroenterology 1992;102:310-313
28. Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, et al. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 1994;20:126-134
29. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980:79:200206
30. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980:21:870-877
31. Helzberg JH, Petersen JM, Boyer JL. Improved survival with primary sclerosing cholangitis: a review of Clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987:92:1869-1875
32. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10:430436
33. Ludwig J, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis. Contemp Issues Surg Pathol 1986;8:193-213
34. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991:100:1710-1717
35. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992:103:18931901
36. Kim WR, Therneau TM, Poterucha JJ, Wiesner RH, Benson JT, Malinchoc M, et al. A revised natural history model for primary sclerosing cholangitis. Hepatology [in press]
37. Shetty K, Rybicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997:25:1049-1053
38. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973:60:646-649
39. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997:3:628-637
40. Farges 0, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995; 117:146-155
41. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451457
42. Ismail T, Angrisani L, Powell JE, Hubscher S, Buckels J, Neuberger J, et al. Primary sclerosing cholangitis: surgical options, prognostic variables and outcome. Br J Surg 1991:78:564-567
43. Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986;6:922-927
44. Danovitch GM, Wilkinson AH, Colonna JO, Busuttil RW. Determinants of renal failure in patients receiving orthotopic liver transplants (OLT) [abstract]. Kidney Int 1987;31:195
45. Neuberger J, Altman DG, Poison R, Buckels J, Rolles K, Elias E, et al. Prognosis after liver transplantation for primary biliary cirrhosis. Transplantation 1989;48:444-447
46. Keiding S, Ericzon BG, Eriksson S, Fiatmark A, Hockerstedt K, Isoniemi H, et al. Survival after liver transplantation of patients with primary biliary cirrhosis in the Nordic countries: comparison with expected survival in another series of transplantations and in an international trial of medical treatment. Scand J Gastroenterol 1990;25:11-18
47. Ricci P, Therneau TM, Malinchoc M, Benson JT, Petz JL, Klintmalm GB, et al. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 1997;25:672-677
48. Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GB, et al. Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989:320:1709-1713
49. Sallie R, O'Grady J, Williams R. Transplantation in primary biliary cirrhosis. J Gastroenterol Hepatol 1991;6:558-562
50. Neuberger JM, Gunson BK, Buckels JA, Elias E, McMaster P. Referral of patients with primary biliary cirrhosis for liver transplantation. Gut 1990:31:1069-1072
51. Bonsel GJ, Klompmaker IJ, van't Veer F, Habbema JD, Sloof MJ. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet 1990:335:493-497
52. Grambsch PM, Dickson ER, Wiesner RH, Langworthy A. Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. Mayo Clin Proc 1989:64:699-704
53. Kirn WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology [in press]
54. Marsh JW Jr, Iwatsuki S, Makowka L, Esquivel CO, Gordon RD, Todo S, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988;207:21-25
55. Langnas AN, Grazi GL, Stratta RJ, Wood RP, Marujo W, Markin RS, et al. Primary sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol 1990:85:1136-1141
56. Esquivel CO, Van Thiel DH, Demetris AJ, Bernardos A, Iwatsuki S, Markus B, et al. Transplantation for primary biliary cirrhosis. Gastroenterology 1988:94:1207-1216
57. Krom RAF, Wiesner RH, Rettke SR, Ludwig J, Southorn PA, Hermans PE, étal. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989:64:84-94
58. Abu-Elmagd KM, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993; 177:335-344
59. UNOS Scientific Registry. UNOS transplant recipient characteristics. UNOS Update 1992 Mar;8:31
60. Evans RW. Executive Summary: The National Cooperative Transplantation Study. Seattle: Battelle-Seattle Research Center; 1991 Jun
61. Williams JW, Vera S, Evans LS. Socioeconomic aspects of hepatic transplantation. Am J Gastroenterol 1987;82:1115-1119
62. Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation: costs, insurance coverage, and reimbursement. In: Evans RW, Manninen DL, Dong FB, editors. The National Cooperative Transplantation Study: Final Report. Vol 4, Chapter 16. Seattle: Battelle-Seattle Research Center; 1991 Jun. p 32
63. Cooper J, Wiesner RH, Dickson ER, Moore R, Beaver S, Anderson J, et al. Severity of disease predicts the cost of liver transplantation using primary biliary cirrhosis as a model [abstract]. Hepatology 1990;12:838
64. Kim WR, Therneau TM, Dickson ER, Evans RW. Preoperative predictors of resource utilization in liver transplantation. Clin Transpl 1995;315-322